BC treatment halts bone mets + protects bones

Possible use in prevention Studies are now beginning that will investigate the use of Everolimus in the early stage of breast cancer – and not only when breast cancer is already advanced. Says Gnant: "Consideration is being given to using the drug preventatively too." This is because Everolimus works directly on the mTOR signal pathway, where it acts as an mTOR inhibitor, blocking the signal pathway, and not just on one specific organ. Gnant: "This gives rise to the hope that it will also be effective and useful on other signal pathways."

Read more at: http://medicalxpress.com/news/2013-03-breast-cancer-treatment-halts-bone.html#jCp

Possible use in prevention Studies are now beginning that will investigate the use of Everolimus in the early stage of breast cancer – and not only when breast cancer is already advanced. Says Gnant: "Consideration is being given to using the drug preventatively too." This is because Everolimus works directly on the mTOR signal pathway, where it acts as an mTOR inhibitor, blocking the signal pathway, and not just on one specific organ. Gnant: "This gives rise to the hope that it will also be effective and useful on other signal pathways."

Read more at: http://medicalxpress.com/news/2013-03-breast-cancer-treatment-halts-bone.html#jCp

Possible use in prevention Studies are now beginning that will investigate the use of Everolimus in the early stage of breast cancer – and not only when breast cancer is already advanced. Says Gnant: "Consideration is being given to using the drug preventatively too." This is because Everolimus works directly on the mTOR signal pathway, where it acts as an mTOR inhibitor, blocking the signal pathway, and not just on one specific organ. Gnant: "This gives rise to the hope that it will also be effective and useful on other signal pathways."

Read more at: http://medicalxpress.com/news/2013-03-breast-cancer-treatment-halts-bone.html#jCp